Revenue from the global urinary catheter market size is set to reach US$ 1.89 billion in 2024 and further rise at 3.6% CAGR to climb to US$ 2.68 billion by the end of 2034.This growth is driven by the increasing prevalence of urological disorders, such as urinary incontinence, benign prostatic hyperplasia (BPH), bladder dysfunction, and kidney stones, alongside the rising incidence of chronic diseases like diabetes and spinal cord injuries that impair bladder function.

As healthcare systems worldwide transition toward patient-centric and home-based care models, urinary catheter manufacturers are focusing on innovation, infection prevention, and user comfort to meet growing patient and clinical demands.

Innovation in Design and Material Driving Growth:

Recent years have seen a surge in technological advancements in urinary catheter design, with manufacturers introducing hydrophilic coatings, antimicrobial layers, and intermittent catheter systems to minimize infection risks and enhance patient comfort.

“Innovation is at the heart of market growth,” notes a senior healthcare analyst at Fact.MR. “Leading manufacturers are investing in catheter technologies that mimic natural urination processes, reduce catheter-associated urinary tract infections (CAUTIs), and enable long-term, comfortable use for chronic care patients.”

Intermittent catheters, in particular, are witnessing notable traction, projected to reach US$ 1.59 billion by 2034, owing to their superior patient compatibility and reduced infection risk for individuals with spinal cord injuries or neurogenic bladder issues.

Post-Surgical and Chronic Care Applications Strengthening Market Base:

Urinary catheters play an essential role in postoperative care, particularly in surgeries involving the prostate, bladder, and lower abdomen. They assist in managing urinary retention, ensuring accurate urine output monitoring, and maintaining bladder function during recovery.

With the number of global surgical procedures rising due to advancements in medical technologies and improved access to healthcare, demand for urinary catheters is expected to increase proportionally.

In chronic care, the growing trend toward home healthcare has spurred demand for self-manageable, user-friendly catheters. Patients and caregivers now prefer devices designed for ease of use, comfort, and hygiene, reflecting the industry’s shift toward convenience and autonomy in long-term care management.

Regional Insights: United States and Japan Lead in Adoption:

North America continues to dominate the global urinary catheter market, capturing 40.3% of total revenue in 2024. The United States, with its advanced healthcare infrastructure and growing geriatric population, is projected to expand from US$ 684 million in 2024 to US$ 1.01 billion by 2034 at a CAGR of 4%.

Manufacturers are drawn to the U.S. market due to strong regulatory standards, rising adoption of antimicrobial-coated and intermittent catheters, and robust reimbursement frameworks.

In Japan, market value is forecasted to climb from US$ 119 million in 2024 to US$ 166 million by 2034, with a 3.4% CAGR. Japan’s focus on medical innovation, coupled with its aging population, has fostered widespread adoption of technologically advanced products like hydrophilic catheters and infection-prevention devices, enhancing patient safety and comfort.

Challenges: Infection Risks and High Servicing Costs:

Despite promising growth, the market faces hurdles related to catheter-associated infections, particularly with central venous catheters (CVCs). The rise of antibiotic-resistant bacteria has made prevention and treatment of bloodstream infections increasingly complex.

Additionally, high servicing costs, stringent regulatory requirements, and product recalls remain key challenges affecting profit margins for manufacturers. Addressing these challenges through cost-efficient production, compliance management, and innovation will be essential for long-term success.

Competitive Landscape: Strategic Alliances and Product Launches:

Global leaders such as B. Braun Melsungen AG, Coloplast Group, Teleflex Inc., Boston Scientific Corporation, and Medtronic Plc continue to dominate the urinary catheter market, supported by strong product portfolios and global distribution networks.

Recent developments highlight the industry’s ongoing transformation:

• Medline & Consure Medical (April 2024): Announced an exclusive partnership for the QiVi MEC male external urine management device to combat CAUTIs and incontinence-related conditions.
• Ingenion Medical Ltd. (April 2024): Received CE approval for Cymactive 2.0R urinary catheter, designed to mimic natural urination, improving comfort for men with chronic urine retention.
• Bright Uro (December 2023): Raised US$ 23 million Series A funding to advance the first wireless, catheter-free urodynamics monitoring system.
• Teleflex (July 2023): Acquired Palette Life Sciences for US$ 600 million, expanding its urology and reproductive health portfolio.
• The Flume Catheter Company (November 2021): Received FDA approval for its advanced substitute for traditional Foley catheters.

These strategic moves emphasize a clear industry shift toward technologically enhanced, patient-friendly, and infection-resistant solutions.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.factmr.com/checkout/8242

Request for Discount: https://www.factmr.com/connectus/sample?flag=S&rep_id=8242

Future Outlook: Pathway to a Safer, Smarter Catheter Ecosystem:

The next decade will see an evolution in urinary catheter manufacturing, with smart sensors, biocompatible materials, and wireless monitoring systems entering mainstream production. Manufacturers are expected to adopt AI-assisted design tools, sustainability-driven materials, and connected healthcare systems to align with next-generation patient needs.

As global healthcare focuses increasingly on post-surgical recovery, home-based care, and chronic disease management, urinary catheter producers have an exceptional opportunity to lead innovation in medical device technology.

For industry leaders, the time to invest in innovation, patient safety, and partnerships is now—as the urinary catheter market transitions into a new era defined by digital health integration, user comfort, and infection prevention excellence.

Explore More Related Studies Published by Fact.MR Research:

Urinary Tract Infection Treatment Market- https://www.factmr.com/report/urinary-tract-infection-treatment-market

Stress Urinary Incontinence Market- https://www.factmr.com/report/3407/stress-urinary-incontinence-market

Genitourinary Cancers Treatment Market- https://www.factmr.com/report/2571/genitourinary-cancers-treatment-market

Transcatheter Pacing System Market- https://www.factmr.com/report/3881/transcatheter-pacing-system-market

Transcatheter Valve Replacement Market- https://www.factmr.com/report/transcatheter-valve-replacement-market

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog